Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Treating rheumatic patients with a malignancy

Figure 3

Risk of cancer relapse from solid organ transplantation according to time between cancer treatment and transplantation (adapted from Penn, 1993, black bars [54] and Penn, 1997, gray bars [53]). The data from 1997, with longer follow-up period and higher patient number, lead to the recommendation of longer waiting time between tumor treatment and transplantation in graft recipients with pre-existing malignancies.

Back to article page